ARTICLE
|
doi:10.20944/preprints202208.0048.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
antibody; immunotherapy; CRISPR/HDR; FC optimization; hybridoma
Online: 2 August 2022 (08:10:26 CEST)